CytomX Therapeutics
CTMX
CTMX
126 hedge funds and large institutions have $422M invested in CytomX Therapeutics in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 34 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 126 → 126 (0)
25% less call options, than puts
Call options by funds: $563K | Put options by funds: $746K
Holders
126
Holding in Top 10
–
Calls
$563K
Puts
$746K
Top Buyers
| 1 | +$48M | |
| 2 | +$27.1M | |
| 3 | +$13.3M | |
| 4 |
BlackRock
New York
|
+$10.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$10.1M |
Top Sellers
| 1 | -$4.73M | |
| 2 | -$3.27M | |
| 3 | -$2.3M | |
| 4 |
Morgan Stanley
New York
|
-$2.25M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$1.87M |